» Articles » PMID: 21774017

Crystal Structure of New Delhi Metallo-β-lactamase Reveals Molecular Basis for Antibiotic Resistance

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2011 Jul 21
PMID 21774017
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

β-Lactams are the most commonly prescribed class of antibiotics and have had an enormous impact on human health. Thus, it is disquieting that an enzyme called New Delhi metallo-β-lactamase-1 (NDM-1) can confer Enterobacteriaceae with nearly complete resistance to all β-lactam antibiotics including the carbapenams. We have determined the crystal structure of Klebsiella pneumoniae apo-NDM-1 to 2.1-Å resolution. From the structure, we see that NDM-1 has an expansive active site with a unique electrostatic profile, which we propose leads to a broader substrate specificity. In addition, NDM-1 undergoes important conformational changes upon substrate binding. These changes have not been previously observed in metallo-β-lactamase enzymes and may have a direct influence on substrate recognition and catalysis.

Citing Articles

Phytosterols as inhibitors of New Delhi metallo-β-lactamase (NDM-1): an in silico study.

Rahman M, Ahsan M, Rehman M, Alajmi M, Khan M Mol Divers. 2024; .

PMID: 39514168 DOI: 10.1007/s11030-024-11020-6.


Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors.

Alkhatabi H, Alatyb H Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338345 PMC: 11435111. DOI: 10.3390/ph17091183.


Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant .

Abdulaal W, Alhakamy N, Asseri A, Radwan M, Ibrahim T, Okbazghi S Front Pharmacol. 2024; 15:1366459.

PMID: 38533260 PMC: 10963397. DOI: 10.3389/fphar.2024.1366459.


Fluorescently Modified NDM-1: A Versatile Drug Sensor for Rapid β-Lactam Antibiotic and Inhibitor Screening.

Chung S, Tam S, Wong W, So P, Cheong W, Mak C ACS Omega. 2024; 9(8):9161-9169.

PMID: 38434906 PMC: 10906033. DOI: 10.1021/acsomega.3c08117.


Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae.

Abdel-Halim M, El-Ganiny A, Mansour B, Yahya G, Latif H, Askoura M BMC Microbiol. 2024; 24(1):67.

PMID: 38413891 PMC: 10898048. DOI: 10.1186/s12866-024-03214-7.


References
1.
Kumarasamy K, Toleman M, Walsh T, Bagaria J, Butt F, Balakrishnan R . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10(9):597-602. PMC: 2933358. DOI: 10.1016/S1473-3099(10)70143-2. View

2.
Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

3.
Materon I, Beharry Z, Huang W, Perez C, Palzkill T . Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1. J Mol Biol. 2004; 344(3):653-63. DOI: 10.1016/j.jmb.2004.09.074. View

4.
Bootsma H, Aerts P, Posthuma G, Harmsen T, Verhoef J, Van Dijk H . Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?. J Bacteriol. 1999; 181(16):5090-3. PMC: 94001. DOI: 10.1128/JB.181.16.5090-5093.1999. View

5.
Bush K . Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010; 13(5):558-64. DOI: 10.1016/j.mib.2010.09.006. View